US FTC seeks more information on Novo Nordisk parent-Catalent deal [Reuters]
Catalent, Inc. (CTLT)
Last catalent, inc. earnings: 2/3 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.catalent.com
Company Research
Source: Reuters
The was announced in February and Novo Nordisk Foundation has since refiled its application to the U.S. FTC seeking regulatory approval for it. Catalent in a regulatory filing on Friday said the companies were in the process of gathering information and documents to respond to FTC's request received on May 2 and intend to continue to cooperate with the regulator. Report this ad Catalent and Novo Holdings expect to close the deal towards the end of calendar year 2024. Novo Holdings is the investment arm of Novo Nordisk's controlling shareholder, the Novo Nordisk Foundation. Coming soon: Get the latest news and expert analysis about the state of the global economy with Reuters Econ World. Sign up Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar Our Standards:
Show less
Read more
Impact Snapshot
Event Time:
CTLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTLT alerts
High impacting Catalent, Inc. news events
Weekly update
A roundup of the hottest topics
CTLT
News
- Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Pharmaceutical Contract Packaging Market Size Expected to Reach USD 36.11 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
- Cell and Gene Therapy Manufacturing Research Report 2024 [Yahoo! Finance]Yahoo! Finance
- Drug Discovery Outsourcing Market size is set to grow by USD 1.79 bn from 2024-2028, robust demand for biosimilars to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
- $19.81 Billion Large Molecule Drug Substance Contract Development and Manufacturing Organization (CDMO) Market Analysis - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F [Yahoo! Finance]Yahoo! Finance
CTLT
Earnings
- 2/9/24 - Miss
CTLT
Sec Filings
- 5/16/24 - Form DEFA14A
- 5/16/24 - Form 8-K
- 5/13/24 - Form 144
- CTLT's page on the SEC website